Company news
Dicot Pharma AB news in 2025
Dicot Pharma AB's news releases, calls and decks from 2025, newest first.
Dicot Pharma Signs Agreement With CRO Ahead Of Phase 2B Study With Lib-01
December 18, 2025
Dicot Pharma Submits Patent Application For LIB-01
November 21, 2025
Dicot Pharma Q3 Loss After Financial Items SEK 16.1 Mln
October 23, 2025
DICOT: Phase 2a study enrollment completed; strong cash position supports next development steps
August 12, 2025
DICOT: Strong warrant uptake and robust cash position support ongoing LIB-01 clinical progress
April 29, 2025
Dicot Pharma's TO 6 subscribed at 96% and provides the company SEK 43.8 million
April 2, 2025
DICOT: LIB-01 advanced in clinical trials, secured funding, and expanded IP, positioning for growth
February 13, 2025